308 related articles for article (PubMed ID: 30655856)
1. Ki-67 is an independent prognostic marker for the recurrence and relapse of oral squamous cell carcinoma.
Jing Y; Zhou Q; Zhu H; Zhang Y; Song Y; Zhang X; Huang X; Yang Y; Ni Y; Hu Q
Oncol Lett; 2019 Jan; 17(1):974-980. PubMed ID: 30655856
[TBL] [Abstract][Full Text] [Related]
2. Tumor expression of miR-448 is a prognostic marker in oral squamous cell carcinoma.
Wei H; Yu K; Liu Y; Li L; Wang G
BMC Cancer; 2020 Aug; 20(1):756. PubMed ID: 32787801
[TBL] [Abstract][Full Text] [Related]
3. Higher Ki67 expression in fibroblast like cells at invasive front indicates better clinical outcomes in oral squamous cell carcinoma patients.
Jing Y; Yang Y; Hao F; Song Y; Zhang X; Zhang Y; Huang X; Hu Q; Ni Y
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30341240
[No Abstract] [Full Text] [Related]
4. Ki-67 from clinically and histologically "normal" distant mucosa as prognostic marker in early-stage (T1-T2N0) oral squamous cell carcinoma: a prospective study.
Montebugnoli L; Gissi DB; Badiali G; Marchetti C; Cervellati F; Farnedi A; Foschini MP
J Oral Maxillofac Surg; 2011 Oct; 69(10):2579-84. PubMed ID: 21292374
[TBL] [Abstract][Full Text] [Related]
5. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.
Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y
Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828
[TBL] [Abstract][Full Text] [Related]
6. [Expression and significance of Ki-67, PI3K and Beclin1 in oral squamous cell carcinoma].
DA Y; Yang Z; Xia MM; Wang MJ
Shanghai Kou Qiang Yi Xue; 2020 Feb; 29(1):75-79. PubMed ID: 32524126
[TBL] [Abstract][Full Text] [Related]
7. Ki-67 Expression as a Prognostic Marker: A Comparative Immunohistochemical Analysis of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Gupta V; Ramalingam K; Yasothkumar D; Debnath D; Sundar V
Cureus; 2023 May; 15(5):e38941. PubMed ID: 37313057
[TBL] [Abstract][Full Text] [Related]
8. Ki-67 Prognostic Value in Different Histological Grades of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Takkem A; Barakat C; Zakaraia S; Zaid K; Najmeh J; Ayoub M; Seirawan MY
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3279-3286. PubMed ID: 30486632
[TBL] [Abstract][Full Text] [Related]
9. Combined overexpression of cadherin 6, cadherin 11 and cluster of differentiation 44 is associated with lymph node metastasis and poor prognosis in oral squamous cell carcinoma.
Ma C; Zhao JZ; Lin RT; Zhou L; Chen YN; Yu LJ; Shi TY; Wang M; Liu MM; Liu YR; Zhang T
Oncol Lett; 2018 Jun; 15(6):9498-9506. PubMed ID: 29805672
[TBL] [Abstract][Full Text] [Related]
10. Mediator of DNA damage checkpoint protein 1 (MDC1) as a prognostic marker for patients with oral squamous cell carcinoma.
Dave JH; Vora HH; Ghosh NR; Trivedi TI
J Oral Pathol Med; 2017 Apr; 46(4):253-258. PubMed ID: 28161894
[TBL] [Abstract][Full Text] [Related]
11. Progression level of extracapsular spread and tumor budding for cervical lymph node metastasis of OSCC.
Yamada SI; Otsuru M; Yanamoto S; Hasegawa T; Aizawa H; Kamata T; Yamakawa N; Kohgo T; Ito A; Noda Y; Hirai C; Kitamura T; Okura M; Kirita T; Ueda M; Yamashita T; Ota Y; Komori T; Umeda M; Kurita H
Clin Oral Investig; 2018 Apr; 22(3):1311-1318. PubMed ID: 28986696
[TBL] [Abstract][Full Text] [Related]
12. Subcellular differential expression of Ep-ICD in oral dysplasia and cancer is associated with disease progression and prognosis.
Somasundaram RT; Kaur J; Leong I; MacMillan C; Witterick IJ; Walfish PG; Ralhan R
BMC Cancer; 2016 Jul; 16():486. PubMed ID: 27421772
[TBL] [Abstract][Full Text] [Related]
13. NRP2, a potential biomarker for oral squamous cell carcinoma.
Kang Y; Zhang Y; Zhang Y; Sun Y
Am J Transl Res; 2021; 13(8):8938-8951. PubMed ID: 34540006
[TBL] [Abstract][Full Text] [Related]
14. High expression of Naa10p associates with lymph node metastasis and predicts favorable prognosis of oral squamous cell carcinoma.
Zeng Y; Zheng J; Zhao J; Jia PR; Yang Y; Yang GJ; Ma JF; Gu YQ; Xu J
Tumour Biol; 2016 May; 37(5):6719-28. PubMed ID: 26662107
[TBL] [Abstract][Full Text] [Related]
15. Macrophage migration inhibitory factor is a novel prognostic marker for human oral squamous cell carcinoma.
Kang Y; Zhang Y; Sun Y
Pathol Res Pract; 2018 Aug; 214(8):1192-1198. PubMed ID: 30041958
[TBL] [Abstract][Full Text] [Related]
16. GDF15 is a potential predictive biomarker for TPF induction chemotherapy and promotes tumorigenesis and progression in oral squamous cell carcinoma.
Yang CZ; Ma J; Zhu DW; Liu Y; Montgomery B; Wang LZ; Li J; Zhang ZY; Zhang CP; Zhong LP
Ann Oncol; 2014 Jun; 25(6):1215-22. PubMed ID: 24669014
[TBL] [Abstract][Full Text] [Related]
17. Increased placenta growth factor mRNA level is significantly associated with progression, recurrence and poor prognosis of oral squamous cell carcinoma.
Cheng SJ; Cheng SL; Lee JJ; Chen HM; Chang HH; Kok SH; Chiang ML; Kuo MY
J Formos Med Assoc; 2013 May; 112(5):253-8. PubMed ID: 23660220
[TBL] [Abstract][Full Text] [Related]
18. Expression of vascular endothelial growth factor is significantly associated with progression and prognosis of oral squamous cell carcinomas in Taiwan.
Cheng SJ; Lee JJ; Kok SH; Chou CH; Chang HH; Yang H; Chiang ML; Kuo MY
J Formos Med Assoc; 2011 Jan; 110(1):50-7. PubMed ID: 21316013
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Significance of Estrogen Receptor Alpha in Oral Squamous Cell Carcinoma.
Doll C; Bestendonk C; Kreutzer K; Neumann K; Pohrt A; Trzpis I; Koerdt S; Dommerich S; Heiland M; Raguse JD; Jöhrens K
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830915
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic value of plasma miR-1290 expression in patients with oral squamous cell carcinoma].
Chen XM; Liu ZZ; Lin JN
Hua Xi Kou Qiang Yi Xue Za Zhi; 2020 Aug; 38(4):371-375. PubMed ID: 32865353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
